Moscow purchased medicines for 2022 under offset contracts for almost 1.3 billion rubles

In 2017, the capital was the first in Russia to conclude offset contracts with investors in the field of production of pharmaceutical products, medical products and food products for dairy kitchens.

In total, five offset contracts have been concluded in the capital, four of which are in the medical field. As part of the contracts, since the beginning of 2022, about 85,000 packages of various medicines have already been delivered to medical organizations. In total, various medicines and medical devices for 2022 were purchased under offset contracts for almost 1.3 billion rubles.

Now drugs and medical products under offset contracts for the capital's healthcare are supplied by Biocad CJSC and Gemamed LLC. During 2022–2023, R-Opra LLC and the Moscow Endocrine Plant will join them.